Dr. Ian Thompson III, MD

• Urology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Utsa - Mba

  2015

• University Of Texas Health Science Center

  Fellowship Hospital, 2013

• Vanderbilt Medical Center

  Internship Hospital, 2008

• University Of Texas Health Sciences Center At San Antonio Long School Of Medicine

  Medical School, 2007

• Texas A&m University

  Undergraduate School, 2002

• Tulane University School Of Medicine

  Medical School, 1980

• English

• Spanish

• HUMAN PAPILLOMAVIRUS TYPES 16, 18 AND 31 SEROSTATUS AND PROSTATE CANCER RISK IN THE PROSTATE CANCER PREVENTION TRIAL, 2009-12-12

• Androgen Receptor CAG Repeat Length and Association with Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial, 2010-10-16

• TRENDS AND CO-TRENDS OF PROSTATE-SPECIFIC ANTIGEN AND BODY MASS INDEX IN A SCREENED POPULATION, 2011-05-07

• Helicobacter PyloriInfection in Texas Hispanic and Non-Hispanic White Men: Implications for Gastric Cancer Risk Disparities, 2017-04-17

• Wide disparity in genetic admixture among Mexican Americans from San Antonio, TX, 2011-05-18

• Finasteride Concentrations and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial, 2015-05-08

• Single and Multivariate Associations ofMSR1, ELAC2, andRNASELwith Prostate Cancer in an Ethnic Diverse Cohort of Men, 2010-01-19

• Roles of Distal and Genic Methylation in the Development of Prostate Tumorigenesis Revealed by Genome-wide DNA Methylation Analysis, 2016-02-29

• Burden among partner caregivers of patients diagnosed with localized prostate cancer within 1 year after diagnosis: an economic perspective, 2013-08-17

• Editorial Comment on adjuvant radiotherapy study, 2008-12-01

• Statins and Finasteride Use Differentially Modify the Impact of Metformin on Prostate Cancer Incidence in Men with Type 2 Diabetes, 2014-12-16

• Insulin-Like Growth Factor-I, Insulin-Like Growth Factor Binding Protein-3 and Risk of Benign Prostate Hyperplasia in the Prostate Cancer Prevention Trial, 2008-09-15

• Peripheral Zone Inflammation is Not Strongly Associated with Lower Urinary Tract Symptom Incidence and Progression in the Placebo Arm of the Prostate Cancer Prevention Trial*, 2016-06-21

• Evaluating the Four Kallikrein Panel of the 4Kscore for Prediction of High-grade Prostate Cancer in Men in the Canary Prostate Active Surveillance Study, 2016-11-23

• Vortioxetine reverses medial prefrontal cortex-mediated cognitive deficits in male rats induced by castration as a model of androgen deprivation therapy for prostate cancer, 2019-05-28

• Serum Lycopene Concentration and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial, 2011-02-18

• Analysis of Serum Total and Free PSA Using Immunoaffinity Depletion Coupled to SRM: Correlation with Clinical Immunoassay Tests, 2012-02-13

• Utilizing metformin to prevent metabolic syndrome due to androgen deprivation therapy (ADT): a randomized phase II study of metformin in non-diabetic men initiating ADT for advanced prostate cancer, 2023-06-19

• Multiplexed targeted mass spectrometry assays for prostate cancer-associated urinary proteins, 2017-10-09

• Single-cell Analysis of Circulating Tumor Cells Identifies Cumulative Expression Patterns of EMT-related Genes in Metastatic Prostate Cancer, 2012-12-31

• SERIAL PERCENT-FREE PSA IN COMBINATION WITH PSA FOR POPULATION-BASED EARLY DETECTION OF PROSTATE CANCER, 2016-03-12

• Promoter hypomethylation of EpCAM-regulatedbone morphogenetic proteingene family in recurrent endometrial cancer, 2013-09-27

• TEN-YEAR FOLLOW-UP OF NEOADJUVANT THERAPY WITH GOSERELIN ACETATE AND FLUTAMIDE PRIOR TO RADICAL PROSTATECTOMY FOR CLINICAL T3 AND T4 PROSTATE CANCER: UPDATE ON SOUTHWEST ONCOLOGY GROUP STUDY 9109, 2013-11-16

• PTEN Loss as Determined by Clinical-grade Immunohistochemistry Assay Is Associated with Worse Recurrence-free Survival in Prostate Cancer, 2015-08-15

• What do the screening trialsreallytell us and where do we go from here?, 2014-02-19

• Serum Retinol and Carotenoid Concentrations and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial, 2015-08-12

• Validation of the association of RECIST changes with survival in men with metastatic castration resistant prostate cancer treated on SWOG study S0421, 2017-05-10

• When and how do we get involved in prostate cancer prevention?, 2009-07-23

• Timing of Adverse Prostate Cancer Reclassification on First Surveillance Biopsy: Results from the Canary Prostate Cancer Active Surveillance Study, 2016-11-01

• A Rare GermlineHOXB13Variant Contributes to Risk of Prostate Cancer in Men of African Ancestry, 2022-01-12

• The Diagnostic Value of Adiponectin Multimers in Healthy Men Undergoing Screening for Prostate Cancer, 2013-12-02

• EVALUATING THE PROSTATE CANCER PREVENTION TRIAL HIGH GRADE PROSTATE CANCER RISK CALCULATOR IN TEN INTERNATIONAL BIOSY COHORTS: RESULTS FROM THE PROSTATE BIOPSY COLLABORATIVE GROUP, 2012-04-22

• Evaluation of Vitamin E and Selenium Supplementation for the Prevention of Bladder Cancer in SWOG Coordinated SELECT, 2012-04-11

• A Germline Variant at 8q24 Contributes to Familial Clustering of Prostate Cancer in Men of African Ancestry, 2020-05-12

• Improved Overall Survival Trends of Men with Newly Diagnosed M1 Prostate Cancer: A SWOG Phase III Trial Experience (S8494, S8894 & S9346), 2012-08-22

• Phase II Evaluation of Early Oral Estramustine, Oral Etoposide and Intravenous Paclitaxel in Combination with Hormone Therapy in Patients with High-Risk Metastatic Adenocarcinoma of the Prostate: Southwest Oncology Group (SWOG) S0032, 2011-02-21

• Effect of Finasteride on Serum Androstenedione and Risk of Prostate Cancer within the Prostate Cancer Prevention Trial: Differential Effect on High and Low Grade Disease, 2014-12-18

• MUC1 Expression by Immunohistochemistry Is Associated with Adverse Pathologic Features in Prostate Cancer: A Multi-Institutional Study, 2016-11-15

• Evaluation of ERG and SPINK1 by Immunohistochemical Staining and Clinicopathological Outcomes in a Multi-Institutional Radical Prostatectomy Cohort of 1067 Patients, 2015-07-14

• Alcohol Consumption, Finasteride and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial, 2009-08-15

• Adding Genetic Risk Score to Family History Identifies Twice as Many High-risk Men for Prostate Cancer: Results from The Prostate Cancer Prevention Trial, 2016-05-16

• Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial, 2015-06-05

• Effect of 5a-Reductase Inhibitor Use on Mortality From Prostate Cancer, 2019-01-29

• Men with Low Serum Cholesterol Have a Lower Risk of High-Grade Prostate Cancer in the Placebo Arm of the Prostate Cancer Prevention Triala, 2009-11-03

• Association between serum phospholipid fatty acids and intraprostatic inflammation in the placebo arm of the Prostate Cancer Prevention Trial, 2015-04-29

• Association of Androgen Metabolism Gene Polymorphisms with Prostate Cancer Risk and Androgen Concentrations: Results from the Prostate Cancer Prevention Trial, 2016-05-10

• Racial variation in the utility of urinary biomarkers, PCA3 and T2ERG, in a large, multicenter study, 2017-01-20

• Effects of vortioxetine on hippocampal-related cognitive impairment induced in rats by androgen deprivation as a model of prostate cancer treatment, 2023-10-03

• SWOG S0353: Phase II Trial of Intravesical Gemcitabine in Patients with Nonmuscle Invasive Bladder Cancer and Recurrence after 2 Prior Courses of Intravesical Bacillus Calmette-Guerin, 2013-04-15

• Urinary TMPRSS2:ERG and PCA3 in an active surveillance cohort: results from a baseline analysis in the Canary Prostate Active Surveillance Study, 2013-03-20

• Metformin for Reducing Racial/Ethnic Difference in Prostate Cancer Incidence for Men with Type 2 Diabetes, 2016-03-29

• Interactions of the Insulin-Like Growth Factor Axis and Vitamin D in Prostate Cancer Risk in the Prostate Cancer Prevention Trial, 2017-04-12

• A model for the design and construction of a resource for the validation of prognostic prostate cancer biomarkers: the Canary Prostate Cancer Tissue Microarray, 2012-12-15

• A Prospective, Multicenter, NCI EDRN Study of [-2]proPSA: Improving Prostate Cancer Detection and Correlating with Cancer Aggressiveness, 2010-03-23

• Enhancement of performance in porous bead-based microchip sensors: Effects of chip geometry on bio-agent capture, 2015-05-21

• Docetaxel and atrasentan versus docetaxel and placebo for men with advanced castration-resistant prostate cancer (SWOG S0421): a randomised phase 3 trial, 2013-07-17

• Colorectal Adenomas in Participants of the SELECT Randomized Trial of Selenium and Vitamin E for Prostate Cancer Prevention, 2016-10-24

• The Development of a Minority Recruitment Plan for Cancer Clinical Trials, 2013-08-23

• The effect of 3-month finasteride challenge on biomarkers for predicting cancer outcome on biopsy: Results of a randomized trial, 2018-10-09

• Nanomechanical biomarkers of single circulating tumor cells for detection of castration resistant prostate cancer, 2014-07-25

• Global Patterns of Prostate Cancer Incidence, Aggressiveness, and Mortality in Men of African Descent, 2013-02-13

• Validation of Genome-Wide Prostate Cancer Associations in Men of African Descent, 2010-11-11

• Race and Treatment Outcomes in Patients With Metastatic Castration-Sensitive Prostate Cancer A Secondary Analysis of the SWOG 1216 Phase 3 Trial Race and Treatment Outcomes in Patients With Metastatic Castration-Sensitive Prostate Cancer, 2023-08-01

• TGF-ß signal rewiring sustains epithelial-mesenchymal transition of circulating tumor cells in prostate cancer xenograft hosts, 2016-10-21

• The Risk of Biopsy-detectable Prostate Cancer using the Prostate Cancer Prevention Trial Risk Calculator in a Community Setting, 2012-05-01

• Fast T2*-Weighted MRI of the Prostate at 3 Tesla, 2011-06-28

• Association of serum carotenoids and retinoids with intraprostatic inflammation in men without prostate cancer or clinical indication for biopsy in the placebo arm of the Prostate Cancer Prevention Trial, 2021-01-29

• Phase III Trial of Selenium to Prevent Prostate Cancer in Men with High-Grade Prostatic Intraepithelial Neoplasia: SWOG S9917, 2011-09-06

• Androgen Receptor CAG Repeat Length and TMPRSS2:ETS Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial, 2014-05-10

• Factors Associated with Adherence to an End-of-study Biopsy: Lessons from the Prostate Cancer Prevention Trial (SWOG-Coordinated Intergroup Study S9217), 2014-07-15

• Plasma vitamin D and prostate cancer risk: Results from the Selenium and Vitamin E Cancer Prevention Trial, 2014-04-14

• PROSPECTIVE STUDY OF HUMAN HERPESVIRUS TYPE 8 SEROSTATUS AND PROSTATE CANCER RISK IN THE PLACEBO ARM OF THE PROSTATE CANCER PREVENTION TRIAL, 2014-10-31

• A multicenter study showsPTENdeletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancer, 2015-05-04

• Development and Validation of a Quantitative Reactive Stroma Biomarker (qRS) for Prostate Cancer Prognosis, 2022-02-15

• Serum Adiponectin, C-peptide and Leptin and Risk of Symptomatic Benign Prostatic Hyperplasia: Results From the Prostate Cancer Prevention Trial, 2009-09-01

• Inflammation in benign prostate tissue and prostate cancer in the finasteride arm of the Prostate Cancer Prevention Trial, 2015-12-29

• A Prospective Study of Chronic Inflammation in Benign Prostate Tissue and Risk of Prostate Cancer: Linked PCPT and SELECT Cohorts, 2017-07-28

• Validation of copy number variants associated with prostate cancer risk and prognosis, 2013-09-17

• Magnetic Resonance Imaging for the Detection of High-Grade Cancer in the Canary Prostate Active Surveillance Study, 2020-04-28

• A case control study of sarcosine as an early prostate cancer detection biomarker, 2015-10-01

• Phase III Intergroup Trial of Adjuvant Androgen Deprivation With or Without Mitoxantrone Plus Prednisone in Patients With High-Risk Prostate Cancer After Radical Prostatectomy: SWOG S9921, 2018-04-06

• A comparison of general, genitourinary, bowel, and sexual quality of life among long term survivors of prostate, bladder, colorectal, and lung cancer, 2020-07-29

• Focusing PSA Testing on Detection of High-Risk Prostate Cancers by Incorporating Patient Preferences Into Decision Making, 2014-09-10

• Body mass index adjusted prostate-specific antigen and its application for prostate cancer screening, 2010-08-24

• Amplification of Distant Estrogen Response Elements Deregulates Target Genes Associated with Tamoxifen Resistance in Breast Cancer, 2013-08-12

• Clinical and Correlative Results of SWOG S0354: a Phase II Trial of CNTO328 (siltuximab), a Monoclonal Antibody against Interleukin-6 (IL-6), in Chemotherapy Pre-treated Patients with Castration-Resistant Prostate Cancer (CRPC), 2010-05-18

• Statin Drug Use Is Not Associated with Prostate Cancer Risk in Men who are Regularly Screened, 2014-02-08

• Transition of a Clinical Trial into Translational Research: The Prostate Cancer Prevention Trial Experience, 2010-08-21

• Selective Detection of Histologically-Aggressive Prostate Cancer: an Early Detection Research Network (EDRN) Prediction Model to Reduce Unnecessary Prostate Biopsies with Validation in the Prostate Cancer Prevention Trial (PCPT), 2011-10-17

• Analytic Validation of a Clinical-Grade PTEN Immunohistochemistry Assay in Prostate Cancer by Comparison toPTENFISH, 2016-05-13

• Limitations of basing screening policies on screening trials: The US Preventive Services Task Force and prostate cancer screening, 2013-01-31

• Androgen Receptor CAG Repeat Length is Not Associated with the Risk of Incident Symptomatic Benign Prostatic Hyperplasia: Results from the Prostate Cancer Prevention Trial, 2010-05-01

• Adjuvant Radiotherapy for Pathologic T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-term Followup of a Randomized Clinical Trial, 2009-01-23

• Correction: Utilizing metformin to prevent metabolic syndrome due to androgen deprivation therapy (ADT): a randomized phase II study of metformin in non-diabetic men initiating ADT for advanced prostate cancer, 2023-10-19

• Low Free Testosterone and Prostate Cancer Risk: A Collaborative Analysis of 20 Prospective Studies, 2018-11-01

• Updating Risk Prediction Tools: A Case Study in Prostate Cancer, 2011-11-17

• Circulating tumor cell telomerase activity as a prognostic marker for overall survival in SWOG 0421: a phase 3 metastatic castration resistant prostate cancer trial, 2014-10-08

• Age-related Cataract in a Randomized Trial of Selenium and Vitamin E in Men: The SELECT Eye Endpoints (SEE) Study, 2014-12-29

• Evaluating The PCPT Risk Calculator in Ten International Biopsy Cohorts: Results from the Prostate Biopsy Collaborative Group, 2011-12-31

• Abiraterone Acetate for metastatic prostate cancer in patients with suboptimal biochemical response to hormone induction, 2017-11-09

• Case-only Methods Identified Genetic Loci Predicting a Subgroup of Men with Reduced Risk of High-grade Prostate Cancer by Finasteride, 2018-12-11

• COOPERATIVE GROUP TRIALS - SOUTHWEST ONCOLOGY GROUP (SWOG) INNOVATIONS IN ADVANCED PROSTATE CANCER, 2010-10-14

• Selenium- or vitamin E-related gene variants, interaction with supplementation, and risk of high-grade prostate cancer in SELECT, 2016-05-06

• PRECISION MEDICINE IN ACTIVE SURVEILLANCE FOR PROSTATE CANCER: DEVELOPMENT OF THE CANARY-EDRN ACTIVE SURVEILLANCE BIOPSY RISK CALCULATOR (ABC), 2015-03-25

• Impact of prostate cancer on sexual relationships: a longitudinal perspective on intimate partners' experiences, 2013-09-30

• Predictive Value of Sp1/Sp3/FLIP Signature for Prostate Cancer Recurrence, 2012-09-13

• Canary Prostate Active Surveillance Study (PASS); Design of a Multi-institutional Active Surveillance Cohort and Biorepository, 2009-09-16

• The association between serum sex steroid hormone concentrations and intraprostatic inflammation in men without prostate cancer and irrespective of clinical indication for biopsy in the placebo arm of the Prostate Cancer Prevention Trial, 2020-06-07

• Serum Androgens and Prostate Cancer Risk: Results From the Placebo Arm of the Prostate Cancer Prevention Trial, 2015-11-20

• Plasma Tocopherols and Risk of Prostate Cancer in the Selenium and Vitamin E Cancer Prevention Trial (SELECT), 2014-06-24

• Finasteride Reduces the Risk of Incident Clinical Benign Prostatic Hyperplasia, 2012-03-14

• Key genes involved in the immune response are generally not associated with intraprostatic inflammation in men without a prostate cancer diagnosis: Results from the Prostate Cancer Prevention Trial, 2016-01-15

• Vitamin E and the Risk of Prostate Cancer: Updated Results of The Selenium and Vitamin E Cancer Prevention Trial (SELECT), 2011-10-12

• Chronic inflammation in benign prostate tissue is associated with high-grade prostate cancer in the placebo arm of the Prostate Cancer Prevention Trial, 2014-04-18

• Yearly Prostate-specific Antigen and Digital Rectal Examination Fluctuations in a Screened Population, 2009-03-14

• Role of Surveillance Biopsy with No Cancer as a Prognostic Marker for Reclassification: Results from the Canary Prostate Active Surveillance Study, 2018-02-09

• Association between variants in genes involved in the immune response and prostate cancer risk in men randomized to the finasteride Arm in the Prostate Cancer Prevention Trial, 2017-03-20

• Contacts with macrophages promote an aggressive nanomechanical phenotype of circulating tumor cells in prostate cancer., 2021-05-27

• The Prognostic Impact of Seminal Vesicle Involvement found at Prostatectomy and the Effects of Adjuvant radiation in those Patients: Data from SWOG 8794, 2008-10-19

• Associations Between Polymorphisms in Genes Related to Oxidative Stress and DNA Repair, Interactions With Serum Antioxidants, and Prostate Cancer Risk: Results From the Prostate Cancer Prevention Trial, 2022-01-14

• Loss of expression of AZGP1 is associated with worse clinical outcomes in a multi-institutional radical prostatectomy cohort, 2016-06-21

• STUDY OF CYTOMEGALOVIRUS SEROSTATUS AND PROSTATE CANCER RISK IN THE PROSTATE CANCER PREVENTION TRIAL, 2012-07-19